Analysis of aromatic DNA adducts and 7,8-dihydro-8-oxo-2'-deoxyguanosine in lymphocyte DNA from a case-control study of lung cancer involving minority populations

Molecular Carcinogenesis

Volumn 27, Issue 1, 2000, Pages 34-46

  Vulimiri, Suryanarayana V ^a   Wu, Xifeng ^b   Baer Dubowska, Wanda ^a,c   De Andrade, Mariza ^b   Detry, Michelle ^b   Spitz, Margaret R ^b   DiGiovanni, John ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

8 oxo dG; Aromatic DNA adducts; DNA damage; Oxidative stress; Smoking

Indexed keywords

BLEOMYCIN; CELL DNA; DEOXYGUANOSINE DERIVATIVE;

ADULT; ARTICLE; CANCER RISK; CHROMATID ABERRATION; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; ETHNIC GROUP; FEMALE; HUMAN; HUMAN CELL; LUNG CANCER; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MUTAGENIC ACTIVITY; PREDICTION; PRIORITY JOURNAL; SMOKING;

AFRICAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DEOXYGUANOSINE; DNA; DNA ADDUCTS; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHOCYTES; MALE; MEXICAN AMERICANS; MIDDLE AGED; MINORITY GROUPS; RISK FACTORS; SMOKING; TEXAS;

EID: 0033982526     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(200001)27:1<34::AID-MC6>3.0.CO;2-G     Document Type: Article

References (67)

1. Cancer facts and figures 1999. Atlanta, GA: American Cancer Society.
2. Shopland DR, Eyre HJ, Pechacek TF. Smoking-attributable cancer mortality in 1991: Is lung cancer now the leading cause of death among smokers in the United States? J Natl Cancer Inst 1991;83:1142-1148.
3. IARC monographs on the evaluation of the carcinogenic risks of chemicals to humans, Tobacco smoking. Lyon, France: International Agency for Research on Cancer; 1986. p 389-394.
4. Sims P. The metabolic activation of chemical carcinogens. Br MedBull 1980;36:11-16.
5. Hemminki K. Nucleic acid adducts of chemical carcinogens and mutagens. Arch Toxicol 1983;52:249-285.
6. McCormick JJ, Maher VM. Cytotoxic and mutagenic effects of specific carcinogen DNA adducts in diploid human fibroblasts. Environ Health Perspect 1983;62:145-155.
7. Morris SM, Helfich RH, Beranek DT, Beland FA. Relationship between specific DNA adducts, cell survival and SCE formation. In: Tice RR, Hollaender A, eds. Basic life science. New York: Plenum Press; 1984. p 353-360.
8. Wogan GN, Gorelick NJ. An overview of chemical and biochemical dosimetry of exposure to genotoxic chemicals. Environ Health Perspect 1985;62:5-18.
9. Bohr VA. Gene-specific damage and repair of DNA adducts and cross-links IARC Scientific Publications 1994;125: 361-369.
10. Denissenko MF, Pao A, Tang M-s, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hot spots in p53. Science 1996;274:430-432.
11. 32P-postlabeling assay. J Natl Cancer Inst 1989;81: 341-347.
12. 32P-postlabeling assay. Carcinogenesis 1992;13:1053-1074.
13. Phillips DH. DNA adducts in human tissues: Biomarkers of exposure to carcinogens in tobacco smoke. Environ Health Perspect 1996;104(suppl. 3):453-458.
14. Kriek E, Rojas M, Alexandrov K, Bartsch H. Polycyclic aromatic hydrocarbon-DNA adducts in humans: Relevance as biomarkers for exposure and cancer risk. Mutat Res 1998;400:215-231.
15. Phillips DH, Hewer A, Grover PL. Aromatic DNA adducts in human bone marrow and peripheral blood cells of iron foundry workers. Carcinogenesis 1986;7:2071-2075.
16. Perera FP, Maye J, Jaretzki A, et al. Comparison of DNA adducts and sister chromatid exchange in lung cancer cases and controls. Cancer Res 1989;49:4446-4451.
17. 32P-post-labeling assay for aromatic DNA adducts in white blood cells of iron foundry workers. Mutat Res 1986;224:485-492.
18. Wiencke JK, Kelsey KT, Varkonyi A, et al. Correlation of DNA adducts in blood mononuclear cells with tobacco carcinogen-induced damage in human lung. Cancer Res 1995;55:4910-4914.
19. Godschalk RWL, Maas LM, vanZandwijk N, et al. Differences in aromatic-DNA adduct levels between alveolar macrophages and subpopulations of white blood cells from smokers. Carcinogenesis 1998;19:819-825.
20. Church DF, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 1985;64:111-126.
21. Pryor WA, Prier DG, Church DF. Electron-spin resonance study of mainstream and sidestream cigarette smoke: nature of the free radicals in gas-phase smoke and in cigarette tar. Environ Health Perspect 1983;54:345-355.
22. Nakayama T, Kaneko M, Kodama M, Nagata C. Cigarette smoke induces DNA single-strand breaks in human cells. Nature 1985;314:462-464.
23. Leanderson P, Tagesson C. Cigarette smoke-induced DNA damage in cultured human lung cells: Role of hydrxyl radicals and endonuclease activation. Chem-Biol Interact 1992; 81(suppl. 8):197-208.
24. Pryor WA. Cigarette smoke and the involvement of free radical reactions in chemical carcinogenesis. Br J Cancer 1987;55(suppl. 8):19-23.
25. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 1997;387: 147-163.
26. Moriya M, Ou C, Bodepudi V, Johnson F, Takeshita M, Grollman AP. Site-specific mutagenesis using a gapped duplex vector: A study of translesion synthesis past i-oxodeoxyguanosine in E. coli. Mutat Res 1991;254: 281-288.
27. Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA. 8-hydroxydeoxyguanosine, an abundant form of oxidative DNA damage causes G to T and A to C substitutions. J Biol Chem 1992;267:166-172.
28. Kamiya H, Miura K, Ishikawa H, Inoue H, Nishimura S, Ohtsuka E. c-Ha-ras containing 8-hydroxyguanme at codon 12 induces point mutations at the modified and adjacent positions. Cancer Res 1992;52:3483-3485.
29. Floyd RA. The role of 8-hydroxydeoxyguanine in carcinogenesis. Carcinogenesis 1990;11:1447-1450.
30. Kasai H, Nishimura S, Kurokawa Y, Hayashi Y. Oral administration of the renal carcinogen, potassium bromate, specifically produces 8-hydroxydeoxyguanosine in rat target organ DNA. Carcinogenesis 1987;8:1959-1961.
31. Fiala ES, Conaway CC, Mathis JE. Oxidative DNA and RNA damage in the livers of Sprague-Dawley rats treated with the hepatocarcinogen 2-nitropropane. Cancer Res 1989;49: 2603-2605.
32. Floyd RA, Watson JJ, Wong PK, Altmiller DH, Rickard RC. Hydroxyl free radical adduct of deoxyguanosine: Sensitive detection and mechanism of formation. Free Radical Res Commun 1986;1:163-172.
33. 32P-postlabeling assay and the basal levels in rat tissues. Carcinogenesis 1996;17:917-924.
34. Kalra J, Chaudhary AK, Prasad K. Increased production of oxygen free radicals in cigarette smokers. Int J Exp Pathol 1991;75:1-7.
35. Kiyosawa H, Suko M, Okudaira H, et al. Cigarette smoking induces formation of 8-hydroxydeoxyguanosine, one of the oxidative DNA damages in human peripheral leukocytes. Free Radical Res Commun 1990;11:23-27.
36. Asami S, Hirano T, Yamaguchi R, Tomioka Y, Itoh H, Kasai H. Increase of a type of oxidative DNA damage, 8-hydroxyguanine, and its repair activity in human leukocytes by cigarette smoking. Cancer Res 1996;56: 2546-2549.
37. Hsu TC, Johnston DA, Cherry LM, et al. Sensitivity to genotoxic events of bleomycin in humans: Possible relationship to environmental carcinogens. Int J Cancer 1989;43: 403-409.
38. Spitz MR, Hsu TC, Wu X-F, Fueger JJ, Amos CI, Roth JA. Mutagen sensitivity as a biologic marker of lung cancer risk in African-Americans. Cancer Epidermol Biomarkers Prev 1995;4:99-103.
39. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:12-15.
40. Collins AR, Dusinska M, Gedik CM, Stetina R. Oxidative damage to DNA: Do we have a reliable biomarker? Environ Health Perspect 1996;104(suppl. 3):465-469.
41. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 1986;7:1543-1551.
42. Randerath K, Lu I-J, Li D. A comparison between different types of covalent DNA modifications (l-compounds, persistent carcinogen adducts and 5-methylcytosine) in regenerating rat liver. Carcinogenesis 1988;9:1984-1948.
43. 32P-postlabelmg. Comparison with cigarette smoke-associated DNA adduct profiles in vivo. Mutat Res 1992; 268:139-153.
44. Kasai H, Nishimura S. Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res 1984;12:2137-2145.
45. Randerath K, Zhou G-D, Monk SA, Randerath E. Enhanced levels in neonatal rat liver of 7,8-dihydro-8-oxo-2′-deoxyguanosine (8-hydroxydeoxyguanosine), a major mutagenic oxidative DNA lesion. Carcinogenesis 1997;18: 1419-1421.
46. Wu X, Hsu TC, Annegers JF, Amos CI, Fueger JJ, Spitz MR. A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases. Cancer Res 1995;55:557-561.
47. Spivack SD, Fasco MJ, Walker VE, Kaminsky LS. Molecular epidemiology of lung cancer. Crit Rev Toxicol 1997;27: 319-365.
48. Tang D, Santella RM, Blackwood AM, et al. A molecular epidemiological case-control study of lung cancer. Cancer Epidemiol Biomarkers Prev 1995;4:341-346.
49. 32P-postlabeling assay from a lung cancer case-control study. Abstract Proc Am Assoc Cancer Res 1998;39:A2532.
50. Ryberg D, Hewer A, Phillips DH, Haugen A. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res 1994; 54:5801-5803.
51. Tang DL, Rundle A, Warburton D, et al. Associations between both genetic and environmental biomarkers and lung cancer: evidence of a greater risk of lung cancer in women smokers. Carcinogenesis 1995;19: 1949-1953.
52. Hou S-M, Yang K, Nyberg F, Hemminki K, Pershange G, Lambert B. Hprt mutant frequency and aromatic DNA adduct level in non-smoking and smoking lung cancer patients and population controls. Carcinogenesis 1999;20:437-444.
53. Wei Q, Spitz MR. The role of DNA repair capacity in susceptibility to lung cancer: A review. Cancer Metastasis Rev 1997;15:295-307.
54. 6-methylguanme repair in fibroblast cultures from patients with lung cancer. Cancer Res 1989;49:5623-5626.
55. Li D, Wang M, Cheng L, Spitz MR, Hittleman WN, Wei Q. In vitro induction of benzo[a]pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer. Cancer Res 1996;56: 3638-3641.
56. Wei Q, Gu J, Cheng L, et al. Benzo[a]pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer. Cancer Res 1996;56:397B-3979.
57. Wei Q, Cheng L, Hong WK, Spitz MR. Reduced DNA repair capacity in lung cancer patients. Cancer Res 1996;56: 4103-4107.
58. Perera FP. Molecular epidemiology: Insights into cancer susceptibility, risk assessment, and prevention. J Natl Cancer Inst 1996;88:496-509.
59. Perera FP. Environment and cancer: Who is susceptible? Science 1997;278:1068-1073.
60. Hegmann KT, Fraser AM, Keaney RP, Moser SE, Nilasena DS, Sedlars M. The effect of age at smoking initiation on lung cancer risk. Epidemiol 1993;4:444-448.
61. Wiencke JK, Thurston SW, Kelsey KT, et al. Early age at smoking initiation and tobacco carcinogen DNA damage in the lung cancer. J Natl Cancer Inst 1999;91:614-619.
62. 32P-postlabeling of aromatic DNA adducts in white blood cells and alveolar macrophages of smokers: Saturation at high exposures. Mutat Res 1997;378:65-75.
63. Asami S, Manabe H, Miyake J, et al. Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung. Carcinogenesis 1997;18:1763-1766.
64. Toraason M. 8-hydroxydeoxyguanosine as a biomarker of workplace exposures. Biomarkers 1999;4:3-26.
65. Liu L, Zhang Q, Feng J, et al. The study of DNA oxidative damage in benzene-exposed workers. Mutat Res 1996; 370:145-150.
66. Collins AR, Gedik CM, Olmedilla B, Southon S, Bellizzi M. Oxidative DNA damage measured in human lymphocytes: Large differences between sexes and between countries, and correlations with heart disease mortality rates. FASEB J 1998;12:1397-1400.
67. Takeuchi T, Nakajima M, Ohta Y, Mure K, Takeshita T, Morimoto K. Evaluation of 8-hydroxydeoxyguanosine, a typical oxidative DNA damage, in human leukocytes. Carcinogenesis 1994;15:1519-1523.